Get the Stockscreener App
4.83
2.62%
-0.13
Curanex Pharmaceuticals Inc Stock (CURX) Forecast
The Curanex Pharmaceuticals Inc (CURX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $59.24, representing a +1,127% increase from the current price of $4.83. The highest analyst price target is $82.48, and the lowest is $36.01.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CURX Price Target
Average 52.51
(+987.12% Upside)
Is Curanex Pharmaceuticals Inc (CURX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 51.15 | Neutral |
| STOCH(9,6) | 60.89 | Neutral |
| STOCHRSI(14) | 37.71 | Neutral |
| MACD(12,26) | 0.1031 | Buy |
| ADX(14) | 19.21 | Neutral |
| William %R | -48.00 | Neutral |
| CCI(14) | 10.27 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.915
Sell
|
4.8963
Sell
|
| MA20 |
4.79
Buy
|
4.8165
Buy
|
| MA50 |
4.6028
Buy
|
4.7672
Buy
|
| MA100 |
4.9286
Sell
|
5.6904
Sell
|
| MA200 |
6.3091
Sell
|
10.49
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, CURX could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on CURX, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 51.15 indicates that CURX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 60.89 indicates that CURX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 37.71 indicates that CURX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.21 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 10.27 indicates that CURX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CURX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Curanex Pharmaceuticals Inc financial reports and earnings history, Curanex Pharmaceuticals Inc (CURX) stock could reach $154.53 by 2030, $850.94 by 2040 and $1,871.78 by 2050. See the projected annual prices until 2050 of the Curanex Pharmaceuticals Inc stock below:
- Curanex Pharmaceuticals Inc (CURX) is expected to reach an average price of $420.96 in 2035, with a high prediction of $465.19 and a low estimate of $421.24. This indicates an $8,616% rise from the last recorded price of $4.83.
- Curanex Pharmaceuticals Inc (CURX) stock is projected to chart a bullish course in 2040, with an average price target of $783.98, representing an $16,132% surge from its current level. The forecast ranges from a conservative $784.06 to a sky-high $850.94.
- Our analysts predict Curanex Pharmaceuticals Inc (CURX) to jump 25,367% by 2045, soaring from $1,230.54 to an average price of $1,230.07, potentially reaching $1,317.97. While $1,230.54 is the low estimate, the potential upside is significant.
- Curanex Pharmaceuticals Inc (CURX) stock is expected to climb by 2050, reaching an average of $1,759.46, a $36,328% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1,871.78 and $1,761.45, respectively, highlighting the market's uncertainty.
Curanex Pharmaceuticals Inc Stock (CURX) Year by Year Forecast
Curanex Pharmaceuticals Inc Stock (CURX) Price Forecast for 2026
The predicted value for Curanex Pharmaceuticals Inc (CURX) in 2026 is set at an average of $41.38. Estimates vary from a peak of $82.48 to a trough of $0.2869, indicating an +756.76% surge from the present price of $4.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $82.28 | $36.01 | $82.48 | +1,603% |
| December, 2026 | $78.22 | $79.22 | $80.37 | +1,519% |
Curanex Pharmaceuticals Inc Stock (CURX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Curanex Pharmaceuticals Inc (CURX) is $42.39, with a high forecast of $76.45 and a low forecast of $8.3245. This indicates an +777.55% increase from the last price of $4.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $75.92 | $77.49 | $76.45 | +1,472% |
| February, 2027 | $72.29 | $72.54 | $74.14 | +1,397% |
| March, 2027 | $64.76 | $64.84 | $70.65 | +1,241% |
| April, 2027 | $59.61 | $60.30 | $62.50 | +1,134% |
| May, 2027 | $48.58 | $49.78 | $53.40 | +905.81% |
| June, 2027 | $43.05 | $43.87 | $45.79 | +791.37% |
| July, 2027 | $39.51 | $39.90 | $40.74 | +717.92% |
| August, 2027 | $31.91 | $32.33 | $37.68 | +560.69% |
| September, 2027 | $27.13 | $27.13 | $29.63 | +461.61% |
| October, 2027 | $22.01 | $22.54 | $24.98 | +355.74% |
| November, 2027 | $14.18 | $14.22 | $19.75 | +193.63% |
| December, 2027 | $7.6346 | $8.3245 | $11.56 | +58.07% |
Curanex Pharmaceuticals Inc Stock (CURX) Price Forecast for 2028
In 2028, Curanex Pharmaceuticals Inc (CURX) is projected to reach an average price of $91.92, with a high projection of $181.88 and a low estimate of $1.9572. This indicates an +1,803% rise from the last price of $4.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $102.08 | $1.9572 | $101.48 | +2,013% |
| February, 2028 | $186.06 | $67.97 | $179.47 | +3,752% |
| March, 2028 | $177.46 | $177.64 | $181.88 | +3,574% |
| April, 2028 | $167.30 | $167.43 | $172.82 | +3,364% |
| May, 2028 | $154.67 | $154.67 | $163.58 | +3,102% |
| June, 2028 | $142.45 | $142.95 | $150.31 | +2,849% |
| July, 2028 | $128.96 | $129.26 | $138.73 | +2,570% |
| August, 2028 | $114.79 | $115.07 | $125.03 | +2,277% |
| September, 2028 | $100.45 | $101.45 | $110.25 | +1,980% |
| October, 2028 | $87.58 | $87.78 | $96.20 | +1,713% |
| November, 2028 | $76.12 | $76.57 | $84.14 | +1,476% |
| December, 2028 | $65.16 | $65.34 | $72.72 | +1,249% |
Curanex Pharmaceuticals Inc Stock (CURX) Price Forecast for 2029
The 2029 price forecast for Curanex Pharmaceuticals Inc Stock (CURX) is $144.76 on average, with a high prediction of $281.29 and a low estimate of $8.2244. This represents an +2,897% increase from the previous price of $4.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $51.53 | $51.57 | $61.54 | +966.84% |
| February, 2029 | $38.36 | $38.97 | $48.03 | +694.24% |
| March, 2029 | $26.31 | $27.09 | $35.02 | +444.65% |
| April, 2029 | $10.28 | $11.27 | $22.93 | +112.80% |
| May, 2029 | $140.06 | $8.2244 | $208.52 | +2,800% |
| June, 2029 | $278.04 | $279.45 | $281.29 | +5,656% |
| July, 2029 | $258.33 | $260.03 | $273.08 | +5,249% |
| August, 2029 | $243.71 | $244.39 | $253.35 | +4,946% |
| September, 2029 | $227.48 | $227.65 | $237.99 | +4,610% |
| October, 2029 | $204.71 | $204.74 | $221.93 | +4,138% |
| November, 2029 | $183.86 | $186.96 | $199.51 | +3,707% |
| December, 2029 | $159.73 | $161.24 | $178.92 | +3,207% |
Curanex Pharmaceuticals Inc Stock (CURX) Price Forecast for 2030
Curanex Pharmaceuticals Inc Stock (CURX) is expected to reach an average price of $197.91 in 2030, with a high forecast of $381.33 and a low forecast of $14.49. This signifies an +3,998% surge from the last price of $4.83.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $142.90 | $143.18 | $154.53 | +2,859% |
| February, 2030 | $127.31 | $127.32 | $137.62 | +2,536% |
| March, 2030 | $108.57 | $108.99 | $120.74 | +2,148% |
| April, 2030 | $87.63 | $87.89 | $103.24 | +1,714% |
| May, 2030 | $69.87 | $70.01 | $82.86 | +1,347% |
| June, 2030 | $51.15 | $51.18 | $64.55 | +958.93% |
| July, 2030 | $27.51 | $28.10 | $45.47 | +469.63% |
| August, 2030 | $316.16 | $14.49 | $315.56 | +6,446% |
| September, 2030 | $383.22 | $275.95 | $381.33 | +7,834% |
| October, 2030 | $359.98 | $361.97 | $375.12 | +7,353% |
| November, 2030 | $340.69 | $341.24 | $350.15 | +6,954% |
| December, 2030 | $310.96 | $311.21 | $332.46 | +6,338% |
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):